当前位置:
X-MOL 学术
›
Nat. Commun.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control.
Nature Communications ( IF 14.7 ) Pub Date : 2020-04-01 , DOI: 10.1038/s41467-020-15532-1 Zhichen Sun 1, 2 , Zhenhua Ren 3 , Kaiting Yang 1, 2 , Zhida Liu 3 , Shuaishuai Cao 1, 2 , Sisi Deng 2 , Lily Xu 4 , Yong Liang 1 , Jingya Guo 1, 2 , Yingjie Bian 1 , Hairong Xu 1 , Jiyun Shi 5 , Fan Wang 5, 6 , Yang-Xin Fu 3 , Hua Peng 1
Nature Communications ( IF 14.7 ) Pub Date : 2020-04-01 , DOI: 10.1038/s41467-020-15532-1 Zhichen Sun 1, 2 , Zhenhua Ren 3 , Kaiting Yang 1, 2 , Zhida Liu 3 , Shuaishuai Cao 1, 2 , Sisi Deng 2 , Lily Xu 4 , Yong Liang 1 , Jingya Guo 1, 2 , Yingjie Bian 1 , Hairong Xu 1 , Jiyun Shi 5 , Fan Wang 5, 6 , Yang-Xin Fu 3 , Hua Peng 1
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
作者更正:下一代靶向肿瘤的IL-2优先促进肿瘤浸润的CD8 + T细胞反应和有效的肿瘤控制。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-04-24
中文翻译:
作者更正:下一代靶向肿瘤的IL-2优先促进肿瘤浸润的CD8 + T细胞反应和有效的肿瘤控制。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。